This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing "This is the only directional lead with built-in sensing capabilities," said Jens Volkmann, ...
Remote DBS programming improved Parkinson symptoms faster and reduced travel burdens, expanding access to specialized care.
Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...
The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual brain activity in ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a rechargeable deep brain stimulation device with remote programming for individuals living ...
Boston Scientific is rolling out the fourth generation Vercise Genus Deep Brain Stimulation System in Europe. The Marlborough, MA-based company said it had received CE mark for the device and would ...
The St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) system with directional lead technology is designed to help patients with Parkinson’s disease or essential tremor gain control of their ...
This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results